Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03576365 |
Recruitment Status :
Recruiting
First Posted : July 3, 2018
Last Update Posted : February 14, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Functional Dysphonia Voice Disorders Dysphonia | Behavioral: VOICE Intervention Arm Behavioral: Information-Only Arm | Not Applicable |
In the investigator's voice clinic, a high prevalence of severe distress has been identified. Distress and voice handicap were positively correlated, and perceived control moderated the relationship. Perceived control is associated with less distress in a variety of medical conditions, has an impact beyond that of coping and personality, and can be increased via targeted intervention.
This is a randomized controlled trial. Participants will be randomly assigned to one of the two groups. Both groups involve completing surveys and receiving information online about voice problem.
Participants complete an initial baseline assessment focused on voice function and emotions, including items from the Perceived Control Scale, Voice Handicap Index-10, Perceived Stress Scale, Brief Symptom Inventory-18. Finally, the participants will complete some brief feedback questions about the material.
Next, twice a week for up to three weeks participants will complete check-ins from the online program. Participants in the intervention arm will complete self-guided exercises and brief assessment questions. Participants in the information-only arm will complete mini knowledge quizzes.
All participants will complete brief a post-intervention assessment parallel to the baseline assessment. Lastly, they will have an opportunity to provide final feedback on their experience.
Follow-up with each participant will occur one and three months after finishing the program. Questionnaires will be sent via email including Voice Handicap Index-10, Present Perceived Control-8, and questions regarding treatment adherence and voice outcomes.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 70 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Masking Description: | Participants are not aware of which treatment arm they are assigned. |
Primary Purpose: | Treatment |
Official Title: | Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention |
Actual Study Start Date : | April 11, 2016 |
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | June 2024 |

Arm | Intervention/treatment |
---|---|
Experimental: VOICE Intervention Arm
Participants participate in the online VOICE program to learn about perceived control and stress reduction to improve voice outcomes.
|
Behavioral: VOICE Intervention Arm
Introductory and background information about voice problems and psychosocial distress
|
Sham Comparator: Information-Only Arm
Participants participate in the information only program to learn about voice problems, anatomy and physiology.
|
Behavioral: Information-Only Arm
General introduction of the program and background on voice related information in an interactive manner
|
- Perceived Control [ Time Frame: 2 weeks ]
Change from baseline assessment using a questionnaire, Perceived Present Control-8 (PPC-8).
The PPC-8 questionnaire has 8 questions about perceptions of present control over their voice problem, assessed on a 4-point Likert-type scale, with scores of 1-4 (1=Strongly Disagree, 2=Disagree Somewhat, 3=Agree Somewhat, 4=Strongly Agree). Total scores range from 1-32. Higher scores indicate more perceived control over the patient's voice problems.
- Voice Handicap [ Time Frame: 2 weeks ]
Change from baseline assessment using a questionnaire, Voice Handicap Index-10 (VHI-10).
The VHI-10 questionnaire has 10 questions about voice problems and the effect it has on the patients life, assessed on a 4-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Almost Always, 4=Always). Total scores range from 0-40. Higher scores indicate a more problematic voice. The clinical cutoff for a problematic voice is a VHI-10 score of 10, where scores >10 indicate voice problems. A change of at least 6 points is clinically significant.
- Perceived Stress [ Time Frame: 2 Weeks ]
Change from baseline assessment using a questionnaire, Perceived Stress Scale-4 (PSS-4).
The PSS-4 questionnaire has 4 questions about perceived stress, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Never, 1=Almost Never, 2=Sometimes, 3=Fairly Often, 4=Very Often). Total scores range from 0-16. Higher scores indicate more perceived stress in the patient's life.
- Psychological Symptoms [ Time Frame: 2 weeks ]
Change from baseline assessment using a questionnaire, Brief Symptom Inventory-18 (BSI-18).
The BSI-18 questionnaire has 18 questions about psychological symptoms, assessed on a 5-point Likert-type scale, with scores of 0-4 (0=Not at all, 1=A little bit, 2=Moderately, 3=Quite a bit, 4=Extremely). Total scores range from 0-72. Higher scores indicate more extreme psychological symptoms. Patients with "High Risk" psychological symptoms have a score of 57 (75 percentile) or greater.
- Intervention Module Acceptability [ Time Frame: Baseline and at 2 weeks ]Examine the acceptability and usability of the adapted intervention based on feedback from participants via a questionnaire.
- Patients' Adherence to Voice Therapy and Treatment [ Time Frame: 2 weeks to 2 years ]Examine treatment adherence indicators available in the participants' medical charts after intervention is completed (e.g.., did they attend recommended speech therapy sessions, how adherent were they to their speech therapy exercise regimens, how many visits did it take for them to reach treatment goals). This will be assessed through a medical chart review and reported as a percent of sessions attended, percent exercises completed, and number of visits. All measures will be given equal weight and be used together to assess treatment adherence.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who are seen at the Otolaryngology Clinic (University of Minnesota Health Clinics and Surgery Center, or Fairview Hospital Maple Grove or Southdale) with Muscle Tension Dysphonia
- Patients between 18-80 years of age experiencing a voice problem
- Scored high (>10) on the Voice Handicap Index (VHI-10)
- Has the ability to complete informed consent process
- Interested in using an online program/intervention
- Has reliable access to internet
Exclusion Criteria:
-
Patients who have clinical need for concurrent treatment will be excluded to decrease confounding introduced by having multiple simultaneous interventions. This may include:
- Concurrent laryngeal lesion requiring immediate operative or other intervention
- Concurrent participation in speech therapy
- Concurrent need for new medications that may directly affect voice-related symptoms
- Participant has a Speech Language Pathology visit scheduled in two weeks or less from when they will start the program (if applicable)
- Unable to read English (as determined by their ability to complete the clinic intake forms)
- Female and pregnant
- Prisoner
- Unable to provide informed consent (e.g., patients with dementia)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03576365
Contact: Ali Stockness, MPH | 6513533018 ext 33018 | nicho656@umn.edu |
United States, Minnesota | |
University of Minnesota Health Maple Grove Clinic | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Ali Stockness, MPH 651-626-3018 ext 63018 voice@umn.edu | |
University of Minnesota Health Clinics and Surgeries Otolaryngology Clinic | Recruiting |
Minneapolis, Minnesota, United States, 55455 | |
Contact: Ali Stockness, MPH 651-626-3018 ext 63018 voice@umn.edu |
Principal Investigator: | Stephanie Misono, MD, MPH | University of Minnesota |
Responsible Party: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT03576365 |
Other Study ID Numbers: |
ENT-2017-25834 K23DC016335-01 ( U.S. NIH Grant/Contract ) |
First Posted: | July 3, 2018 Key Record Dates |
Last Update Posted: | February 14, 2023 |
Last Verified: | February 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Perceived Control Distress |
Dysphonia Hoarseness Voice Disorders Laryngeal Diseases Respiratory Tract Diseases |
Otorhinolaryngologic Diseases Neurologic Manifestations Nervous System Diseases Respiration Disorders Signs and Symptoms, Respiratory |